Eric Curtis

Eric Curtis

Chief Operating Officer chez WINDTREE THERAPEUTICS, INC.

Fortune : 5 636 $ au 31/03/2024

56 ans
Health Technology
Consumer Services
Health Services

Profil

Eric L.
Curtis
currently works at Windtree Therapeutics, Inc., as Chief Operating Officer & Senior Vice President from 2020.
Mr. Curtis also formerly worked at Centurion BioPharma Corp., as President & Chief Executive Officer, LadRx Corp., as President & Chief Operating Officer from 2018 to 2020, Aegerion Pharmaceuticals, Inc., as President-US Commercial from 2014 to 2016, and Bayer HealthCare, as Vice President & General Manager-Rare Disease from 2012 to 2014.
Mr. Curtis received his undergraduate degree from the University of Pittsburgh and Masters Business Admin degree in 1999 from The Pennsylvania State University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
16/04/2024 15 920 ( 0,19% ) 5 636 $ 31/03/2024

Postes actifs de Eric Curtis

SociétésPosteDébut
WINDTREE THERAPEUTICS, INC. Chief Operating Officer 09/03/2020
Tous les postes actifs de Eric Curtis

Anciens postes connus de Eric Curtis

SociétésPosteFin
LADRX CORPORATION President 08/03/2020
AEGERION PHARMACEUTICALS, INC. Corporate Officer/Principal 01/01/2016
Corporate Officer/Principal 01/01/2014
Centurion BioPharma Corp. Chief Executive Officer -
Voir l'expérience en détail de Eric Curtis

Formation de Eric Curtis

University of Pittsburgh Undergraduate Degree
The Pennsylvania State University Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Eric Curtis

Relations

100 +

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
LADRX CORPORATION

Health Technology

WINDTREE THERAPEUTICS, INC.

Health Technology

Entreprise privées3

Health Technology

Health Services

Centurion BioPharma Corp.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Eric Curtis